![](/img/cover-not-exists.png)
PCN42 CABOZANTINIB VERSUS STANDARD-OF-CARE COMPARATORS: A NETWORK META-ANALYSIS OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN FIRST-LINE TREATMENT OF ADVANCED RENAL CELL CARCINOMA
Lister, J., Pafitas, S., Meng, J., Wiecek, W., Schmidt, E., Zagorska, A., Marteau, F.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.239
Date:
November, 2019
File:
PDF, 315 KB
2019